Holen Sie sich die Stockscreener-App
192.03
0.03%
-0.05
Vorhandelsmarkt:
190.51
-1.52
-0.79%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Dementia Treatment Market Booming with Rapid Growth Through - openPR.com
How (BIIB) Movements Inform Risk Allocation Models - Stock Traders Daily
Biogen Receives Honorable Mention From Fast Company's World Changing Ideas Awards - CSRwire
Biogen-Funded Collaboration with Americares and Harvard Chan C-CHANGE Recognized by the Clinton Global Initiative - CSRwire
Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative - CSRwire
Biogen Included in 2022 Bloomberg Gender-Equality Index - CSRwire
Skandinaviska Enskilda Banken AB publ Has $4.07 Million Position in Biogen Inc. $BIIB - MarketBeat
Barclays Upgrades Biogen (NASDAQ:BIIB) to Hold - MarketBeat
Barclays Initiates Coverage of Biogen (BIIB) with Equal-Weight Recommendation - Nasdaq
Beyond The Numbers: 21 Analysts Discuss Biogen Stock - Benzinga
Biogen’s BIIB091 MS Trial Reaches Completion, Setting Up a Key Pipeline Catalyst - TipRanks
Biogen (BIIB) Receives New Analyst Coverage with Equal-Weight Ra - GuruFocus
Barclays initiates Biogen stock coverage with $185 price target - Investing.com
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Stock Position in Biogen Inc. $BIIB - MarketBeat
New Biogen Chair Freire May Recast Partnerships And Capital Priorities - Yahoo Finance
Eisai & Biogen Canada Disagree With Canada's Drug Agency's Leqembi Reimbursement Rejection - TradingView
Eisai Maintains Commitment to People Living with Early Alzheimer's Disease Despite CDA-AMC Draft Recommendation: Patients Deserve Access to Effective Treatment - Newswire Canada
Assessing Biogen (BIIB) Valuation As Shares Gain 18.1% In 30 Days And 42% Over One Year - Yahoo Finance
Biogen (BIIB) Valuation Check After Earnings Momentum And Analyst Optimism - simplywall.st
NEOS Investment Management LLC Boosts Position in Biogen Inc. $BIIB - MarketBeat
Multiple Sclerosis Therapeutics Market to Reach USD 46.22 - openPR.com
Aberdeen Group plc Cuts Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - GlobeNewswire Inc.
Biogen head of pharm ops Murphy buys $585 in stock By Investing.com - Investing.com Canada
Biogen head of pharm ops Murphy buys $585 in stock - Investing.com
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat
Wedbush lifts PT on Biogen Inc. (BIIB) to $187 from $178 – here’s why - MSN
5,611 Shares in Biogen Inc. $BIIB Purchased by Caprock Group LLC - MarketBeat
Biogen Stock Performance 2026 | Financial Results & Analyst RatingsNews and Statistics - IndexBox
What Price Targets Have Wall Street Analysts Set for Biogen Shares? - Bitget
What Are Wall Street Analysts' Target Price for Biogen Stock? - Barchart.com
AlphaQuest LLC Sells 10,789 Shares of Biogen Inc. $BIIB - MarketBeat
Biogen Appoints Dr. Gabriela Freire as Board Chair While Immunic Inc. Searches for New CEO - geneonline.com
Early Diagnosis Kit for Alzheimer's Disease Market Outlook - openPR.com
Rhumbline Advisers Has $40.51 Million Position in Biogen Inc. $BIIB - MarketBeat
What are Biogen Inc.’s recent SEC filings showingMarket Risk Report & Growth Oriented Trade Recommendations - mfd.ru
Biogen’s New Therapies Surpass US$1 Billion In Sales Might Change The Case For Investing In BIIB - simplywall.st
LSV Asset Management Grows Position in Biogen Inc. $BIIB - MarketBeat
Oppenheimer & Co. Inc. Has $1.91 Million Stock Position in Biogen Inc. $BIIB - MarketBeat
Clinically Isolated Syndrome Treatment Market Size 2030 US$ 2.4 - openPR.com
BIIB: Late-stage lupus therapies and a diverse immunology pipeline target major unmet needs - TradingView
Biogen Spotlights Lupus Pipeline at Piper Sandler Symposium: Litifilimab, Dapirolizumab in Focus - MarketBeat
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here’s Why - Insider Monkey
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178Here's Why - Finviz
Is Biogen (NASDAQ:BIIB) Using Too Much Debt? - 富途牛牛
There May Be Reason For Hope In Biogen's (NASDAQ:BIIB) Disappointing Earnings - simplywall.st
Krilogy Financial LLC Invests $1.18 Million in Biogen Inc. $BIIB - MarketBeat
Biogen's (NASDAQ:BIIB) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
The 5 Most Interesting Analyst Questions From Biogen's Q4 Earnings Call - Finviz
Biogen Inc. $BIIB Shares Sold by Illinois Municipal Retirement Fund - MarketBeat
The 5 Most Interesting Analyst Questions From Biogen’s Q4 Earnings Call - Yahoo Finance
Maria Freire to replace Caroline Dorsa as Biogen chair - The Pharma Letter
Leuthold Group LLC Acquires New Shares in Biogen Inc. $BIIB - MarketBeat
Stargardt Disease Therapeutics Market to Hit US$1,385.6M - openPR.com
Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… - marketscreener.com
Biogen Inc. (BIIB) Announces Leadership Transition in Board of D - GuruFocus
Biogen’s profit forecast tops estimates on cost-cutting - MSN
Biogen (BIIB) Valuation Check After Q4 Beat And Momentum In New Drugs Like Leqembi - simplywall.st
FMR LLC's Strategic Acquisition of Biogen Inc Shares - GuruFocus
Biogen Beats Pharmacies' MS Drug Monopoly Suit, For Now - Law360
Biogen (BIIB) Appoints Maria Freire as Upcoming Chair of Board - GuruFocus
Biogen Announces Board Chair Caroline Dorsa to Step Down - TipRanks
Biogen Announces Board Chair Transition - Biogen
Biogen Inc. - Via Ritzau
0.78%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):